V383 Reporting adverse outcomes
Written V0383 on the CMS-2567 and in QCOR.
Cited on this tag? What happens after a citation · One-page sheet for the binder
The regulation
§ 494.50(c)(2) – When clinically indicated (for example, after adverse patient reactions), the facility must – (iii) Report the adverse outcomes to the FDA and other Federal, State or local government agencies as required by law.
CMS's interpretive guidance
Interpretive Guidance § 494.50(c)(2)(iii)
The dialyzer manufacturer may or may not be responsible for reporting adverse outcomes related to reprocessing/reuse, depending on their legal liabilities. This regulation, however, requires the facility to be responsible for reporting any adverse outcomes potentially related to reprocessing/reuse, as required by law. Facility policy should address adverse occurrence reporting.
Connected tags
Tags whose guidance points here
https://middlemolecule.com/rulebook/tags/v383/